Pages that link to "Q40128209"
Jump to navigation
Jump to search
The following pages link to Clive R. Seed (Q40128209):
Displaying 50 items.
- Hepatitis E virus: do locally acquired infections in Australia necessitate laboratory testing in acute hepatitis patients with no overseas travel history? (Q27011308) (← links)
- Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey (Q27487786) (← links)
- Emerging infectious disease agents and blood safety in Australia: spotlight on Zika virus (Q30145544) (← links)
- Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk (Q30145555) (← links)
- Antibodies to Leptospira among blood donors in higher-risk areas of Australia: possible implications for transfusion safety (Q30833120) (← links)
- Seroprevalence of Antibodies to Ross River and Barmah Forest Viruses: Possible Implications for Blood Transfusion Safety After Extreme Weather Events (Q30881753) (← links)
- Emerging viral threats to the Australian blood supply (Q33368262) (← links)
- Hepatitis E virus infections in travellers: assessing the threat to the Australian blood supply (Q33739483) (← links)
- No evidence of a significantly increased risk of transfusion-transmitted human immunodeficiency virus infection in Australia subsequent to implementing a 12-month deferral for men who have had sex with men. (Q34128173) (← links)
- The current status and potential role of laboratory testing to prevent transfusion-transmitted malaria (Q36190649) (← links)
- Hepatitis E virus seroepidemiology: a post-earthquake study among blood donors in Nepal (Q36204155) (← links)
- Implications of dengue outbreaks for blood supply, Australia (Q36825504) (← links)
- A Comparative Study of Assay Performance of Commercial Hepatitis E Virus Enzyme-Linked Immunosorbent Assay Kits in Australian Blood Donor Samples (Q37424582) (← links)
- Mitigating the Risk of Transfusion-Transmitted Dengue in Australia (Q37443189) (← links)
- Can blood tranfusion transmit cancer? A literature review (Q37775323) (← links)
- Surveillance of transfusion-transmissible infections comparison of systems in five developed countries (Q37938206) (← links)
- The Epidemiology of Imported Malaria and Transfusion Policy in 5 Nonendemic Countries (Q38453746) (← links)
- Hepatitis E virus RNA in Australian blood donors: prevalence and risk assessment. (Q38612287) (← links)
- Re-examining blood donor deferral criteria relating to injecting drug use. (Q38664406) (← links)
- Refining the risk estimate for transfusion-transmission of occult hepatitis B virus (Q39450759) (← links)
- Detection of emergent strains of West Nile virus with a blood screening assay (Q40127918) (← links)
- Blood safety implications of donors using HIV pre-exposure prophylaxis (Q40261341) (← links)
- Duration of Ross River viraemia in a mouse model--implications for transfusion transmission (Q40311855) (← links)
- Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus (Q40383406) (← links)
- The risk of dengue transmission by blood during a 2004 outbreak in Cairns, Australia. (Q40391653) (← links)
- Hepatitis E virus RNA in Australian blood donations (Q40499922) (← links)
- Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5' non-coding region (Q40513893) (← links)
- Assessing the accuracy of three viral risk models in predicting the outcome of implementing HIV and HCV NAT donor screening in Australia and the implications for future HBV NAT. (Q40622701) (← links)
- Re-evaluating the residual risk of transfusion-transmitted Ross River virus infection. (Q40839225) (← links)
- The residual risk of transfusion-transmitted cytomegalovirus infection associated with leucodepleted blood components (Q41100504) (← links)
- First reported case of transfusion-transmitted Ross River virus infection (Q41439203) (← links)
- Infectivity of blood components from donors with occult hepatitis B infection - results from an Australian lookback programme (Q41734031) (← links)
- Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia. (Q41928215) (← links)
- Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection (Q42230165) (← links)
- A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening (Q42257442) (← links)
- Hepatitis E virus and implications for blood supply safety, Australia. (Q42968684) (← links)
- Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. (Q42992279) (← links)
- Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. (Q43036225) (← links)
- Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA. (Q43040836) (← links)
- The risk of HIV, HBV, HCV and HTLV infection among musculoskeletal tissue donors in Australia (Q43041881) (← links)
- Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies. (Q43041997) (← links)
- Emerging infectious disease outbreaks: estimating disease risk in Australian blood donors travelling overseas (Q43047264) (← links)
- Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests (Q43047999) (← links)
- Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010. (Q43406238) (← links)
- Malaria antibody persistence correlates with duration of exposure (Q43516976) (← links)
- A refined method for estimating the size of the potential blood donor pool in Australia. (Q44007760) (← links)
- Compliance with the current 12-month deferral for male-to-male sex in Australia (Q44061759) (← links)
- Two cases of asymptomatic HBV "vaccine breakthrough" infection detected in blood donors screened for HBV DNA. (Q44143038) (← links)
- Deferral of males who had sex with other males (Q44570683) (← links)
- International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. (Q44626193) (← links)